Skip to main content
Geoffrey Ku, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

GeoffreyYuyatKuMD

Oncology New York, NY

Gastrointestinal Cancer, Hematologic Oncology

Associate Attending physician

Overview of Dr. Ku

Dr. Geoffrey Ku is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 15 years. He is one of 464 doctors at Memorial Sloan Kettering Cancer Center and one of 88 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2002 - 2005
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2002

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2012 - 2025
  • NJ State Medical License
    NJ State Medical License 2019 - 2025

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Zymeworks Announces Abstract for Zanidatamab in First-Line HER2-Expressing Gastroesophageal Cancers (GEA) at the European Society for Medical Oncology (ESMO) Annual Congress
    Zymeworks Announces Abstract for Zanidatamab in First-Line HER2-Expressing Gastroesophageal Cancers (GEA) at the European Society for Medical Oncology (ESMO) Annual CongressSeptember 12th, 2021
  • Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway
    Current Treatment of Esophageal Cancer and Promising Clinical Trials UnderwayMarch 13th, 2019
  • Immunotherapy Treatments Only Just Emerging in Esophageal, Gastric Cancers
    Immunotherapy Treatments Only Just Emerging in Esophageal, Gastric CancersJanuary 17th, 2017

Hospital Affiliations